Search Details

Word: bristols (lookup in dictionary) (lookup stats)
Dates: during 1990-1999
Sort By: most recent first (reverse)


Usage:

...contribution to improved understanding of the Pentateuch would be to allocate a portion of this film's profits to subsidizing independent scholarly research into the Old Testament characters. The Prince of Egypt's expected income would hardly be dented by funding a substantial annual Moses Prize. DAVID W. FAULKNER Bristol, England...

Author: /time Magazine | Title: Letters: Jan. 11, 1999 | 1/11/1999 | See Source »

...want to go to the University of Bristol in England, and study stereotype suppression," said Dunn. "I have read a lot on the subject by a professor at the university, and it would be a great opportunity to work with...

Author: By Peter D. Henninger, CONTRIBUTING WRITER | Title: University Announces Rhodes, Marshall Endorsements | 9/30/1998 | See Source »

...destroyed a range of tumors in mice. The results were startling enough that they merited testing in people--which is exactly what Pluda, at the National Cancer Institute, intends to do. How fast those studies can begin depends on how much angiostatin and endostatin EntreMed and its business partner, Bristol-Myers Squibb, can produce and whether they can figure out which fragment to focus on first...

Author: /time Magazine | Title: The Hope & The Hype | 5/18/1998 | See Source »

...cancers. Dr. Edward Scolnick discovered the RAS gene in rats while working at the National Cancer Institute in 1978. Now president of Merck Research Laboratories, he is overseeing the development of a drug that stops the RAS protein from sending its malignant message. Several other big drug companies, including Bristol-Myers Squibb, Johnson & Johnson and Schering-Plough, are testing similar drugs. "We think the odds are that if you treat people with a good RAS drug, you will produce some clinical benefit," says Scolnick. Finding a new kind of cancer therapy based on gene discoveries like his own is, Scolnick...

Author: /time Magazine | Title: Molecular Revolution | 5/18/1998 | See Source »

Within a year or two, EntreMed and its partner in the project, Bristol-Myers-Squibb, will probably figure out how to make angiostatin in quantity. At that point the companies will have to apply to the FDA for permission to market them. But before the agency gives its blessing, the companies have to show that the medications work in humans, and that they don't have terrible side effects. Normally, that's a five- or six-stage process that can last 10 years or more...

Author: /time Magazine | Title: Why Do I Have To Wait So Long? | 5/18/1998 | See Source »

Previous | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | Next